Bente Elisabeth Moen | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

 

Innovative Research Award

Bente Elisabeth Moen
University of Bergen, Norway
Bente Elisabeth Moen
Affiliation University of Bergen
Country Norway
Scopus ID 7005903229
Documents 316
Citations 7,639
h-index 45
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-0435-3124

The Innovative Research Award recognizes sustained scholarly excellence, research quality, scientific influence, and meaningful contributions to society through evidence-based research. Professor Bente Elisabeth Moen has established an internationally recognized academic profile in occupational medicine, environmental health, and public health research. Her extensive publication record, high citation impact, and interdisciplinary collaborations demonstrate a consistent commitment to improving occupational safety, environmental exposure assessment, and preventive healthcare strategies.[1]

Abstract

Professor Bente Elisabeth Moen has contributed substantially to occupational medicine, workplace epidemiology, environmental exposure research, and preventive health sciences. Her research portfolio includes investigations of pesticide exposure, occupational respiratory health, industrial hygiene, workplace safety culture, and environmental risk assessment. The combination of extensive scholarly productivity and strong citation performance illustrates sustained scientific influence and international research visibility.[1]

Keywords

  • Occupational Medicine
  • Environmental Health
  • Public Health
  • Occupational Epidemiology
  • Industrial Hygiene
  • Preventive Medicine

Introduction

Occupational and environmental health research plays an essential role in protecting workers and improving population well-being. Professor Moen’s investigations have addressed occupational exposure to hazardous substances, respiratory disorders, pesticide exposure, workplace injury prevention, and environmental determinants of health. These studies provide evidence supporting improved occupational policies and preventive interventions across diverse international settings.[2]

Research Profile

With 316 indexed publications, 7,639 citations, and an h-index of 45, Professor Moen demonstrates a sustained record of scientific productivity and scholarly influence. Her collaborations span occupational medicine, environmental epidemiology, public health, and workplace safety, reflecting multidisciplinary engagement with global health challenges.[1]

Research Contributions

  • Occupational exposure assessment.
  • Environmental health epidemiology.
  • Respiratory disease prevention.
  • Pesticide exposure research.
  • Construction workplace safety studies.
  • Global occupational health collaborations.

Publications

  1. Neurodevelopment in children born to women exposed to pesticides during pregnancy. PLOS One (2025).
  2. Occupations and Risk of Head and Neck Cancers: A Case–Control Study in Tanzania. International Journal of Environmental Research and Public Health (2025).
  3. Occupational Pesticide Exposure Risks and Gendered Experiences Among Women in Horticultural Farms in Northern Tanzania.
  4. Reduced lung function among non-smoking workers in the paper industry in Ethiopia.
  5. Association between safety climate, safety participation, safety compliance, and occupational injuries among workers in large-scale building construction projects in Ethiopia.

Research Impact

The research output demonstrates significant international influence through citation performance, interdisciplinary collaboration, and continuous publication in peer-reviewed journals. The work supports evidence-based occupational health policies, workplace safety initiatives, environmental exposure assessment, and preventive medicine.[1]

Award Suitability

Considering the sustained publication record, established citation impact, internationally recognized research profile, and continued contribution to occupational and environmental health sciences, Professor Bente Elisabeth Moen demonstrates qualifications consistent with the objectives of the Global Innovation Technologist Awards. The research portfolio reflects long-term scholarly excellence and measurable scientific impact across multiple areas of medicine and public health.[1]

Conclusion

Professor Bente Elisabeth Moen has developed a distinguished academic career characterized by sustained research productivity, interdisciplinary collaboration, and internationally recognized contributions to occupational and environmental health sciences. Her scholarly achievements, research quality, and measurable scientific influence provide a strong foundation for recognition through the Innovative Research Award.

External Links

References

  1. Scopus Author Profile. Bente Elisabeth Moen. Available at:
    https://www.scopus.com/authid/detail.uri?authorId=7005903229
  2. Moen BE et al. Neurodevelopment in children born to women exposed to pesticides during pregnancy. PLOS One (2025).
    DOI: 10.1371/journal.pone.0326007
  3. Occupations and Risk of Head and Neck Cancers: A Case–Control Study in Tanzania.
    DOI: 10.3390/ijerph22111643
  4. Occupational Pesticide Exposure Risks and Gendered Experiences Among Women in Horticultural Farms in Northern Tanzania.
    DOI: 10.3390/ijerph22101529
  5. Reduced lung function among non-smoking workers in the paper industry in Ethiopia.
    DOI: 10.1007/s00420-025-02163-6
  6. Association between safety climate, safety participation, safety compliance, and occupational injuries among workers in large-scale building construction projects in Ethiopia.
    DOI: 10.1007/s00420-025-02164-5

GΓΌlsΓΌm Kaya | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

GΓΌlsΓΌm Kaya
Affiliation Yalova University
Country Turkey
Scopus ID 56589615100
Documents 17
Citations 731
h-index 8
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
Google Scholar ID d9woUXQAAAAJ

GΓΌlsΓΌm Kaya
Yalova University, Turkey

GΓΌlsΓΌm Kaya is a researcher affiliated with Yalova University, Turkey, whose scholarly activities focus on medicine and health sciences, particularly infectious diseases, antimicrobial stewardship, hospital epidemiology, and infection prevention. Her publication record demonstrates collaborative participation in internationally recognized multicenter investigations addressing healthcare-associated infections, surveillance systems, and evidence-based clinical practice. Through contributions to high-impact journals and multinational research networks, her work supports improved patient safety and infection control strategies in healthcare institutions while advancing scientific understanding of nosocomial infections.[1]

Abstract

This article summarizes the academic profile of GΓΌlsΓΌm Kaya in the context of the Innovative Research Award. Her scholarly contributions encompass infection prevention, antimicrobial utilization, hospital surveillance, and clinical outcomes associated with healthcare-associated infections. Participation in influential international collaborations, including the International Nosocomial Infection Control Consortium (INICC), has contributed to globally cited publications supporting evidence-based infection control practices.[2]

Keywords

Healthcare-associated infections, Infection control, Hospital epidemiology, Antimicrobial stewardship, Nosocomial infections, Clinical microbiology, Patient safety, Medicine and Health Sciences.

Introduction

Modern healthcare systems increasingly rely on multidisciplinary research to reduce infection-related morbidity and improve treatment quality. GΓΌlsΓΌm Kaya has contributed to this objective through collaborative investigations involving surveillance data, antibiotic utilization, and infection prevention. These studies support healthcare policy development and promote standardized approaches to patient safety in hospitals across multiple countries.[3]

Research Profile

According to the supplied scholarly metrics, the researcher has published 17 Scopus-indexed documents, received 731 citations, and achieved an h-index of 8. Her work primarily addresses infectious diseases, antimicrobial therapy, hospital-acquired infections, and epidemiological surveillance. Collaboration with international researchers demonstrates active participation in globally recognized scientific initiatives that generate evidence for healthcare quality improvement.[1]

Research Contributions

Major research contributions include participation in multinational INICC surveillance reports covering dozens of countries, investigations of surgical site infection rates across Turkey, multicenter assessments of antibiotic consumption, and clinical evaluations of antimicrobial therapies for Gram-negative nosocomial infections. These studies provide valuable epidemiological evidence supporting infection control guidelines and healthcare quality assessment.[2]

Publications

  • International Nosocomial Infection Control Consortium report covering 50 countries (2016).
  • INICC device-associated infection report involving 43 countries (2014).
  • Surgical site infection rates across sixteen Turkish cities.
  • Multicenter prevalence study of antibiotic consumption in Turkish hospitals.
  • Clinical outcomes of cefoperazone-sulbactam versus piperacillin-tazobactam therapy.

Research Impact

The citation performance of GΓΌlsΓΌm Kaya reflects sustained scholarly visibility within medicine and health sciences. Highly cited collaborative publications have informed international surveillance practices and strengthened evidence supporting infection prevention initiatives. The combination of clinical relevance, multinational collaboration, and measurable citation impact illustrates meaningful academic influence within the field.[4]

Award Suitability

The research portfolio demonstrates qualities commonly associated with international academic recognition, including collaborative scholarship, publication in peer-reviewed journals, measurable citation impact, and contributions to evidence-based healthcare practice. These characteristics align with the objectives of the Global Innovation Technologist Awards in recognizing research that advances innovation and scientific excellence within medicine and health sciences.[5]

Conclusion

GΓΌlsΓΌm Kaya has established a scholarly profile characterized by collaborative clinical research, internationally cited publications, and contributions to infection prevention and antimicrobial stewardship. Her work supports healthcare quality improvement through evidence generation and multidisciplinary cooperation, making her academic achievements noteworthy within the broader field of medicine and health sciences.[6]

References

  1. Elsevier. (n.d.). Scopus author details: GΓΌlsΓΌm Kaya, Author ID 56589615100.
    https://www.scopus.com/pages/authors/56589615100
  2. Rosenthal VD, et al. (2016). International Nosocomial Infection Control Consortium report. American Journal of Infection Control.
  3. Rosenthal VD, et al. (2014). INICC report: Device-associated module.
    https://doi.org/10.1016/j.ajic.2014.05.029
  4. Leblebicioglu H, et al. (2015). Surgical site infection rates in Turkey.
    https://doi.org/10.1016/j.ajic.2014.08.017
  5. Guclu E, Kaya G, et al. (2020). The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality.
    https://doi.org/10.1080/1120009X.2019.1696735
  6. Guclu E, et al. (2017). Antibiotic consumption in Turkish hospitals.
    https://doi.org/10.1080/1120009X.2016.1235738

David ArgΓΌelles | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

David ArgΓΌelles
University of Cordoba, Spain

David ArgΓΌelles
Affiliation University of Cordoba
Country Spain
Scopus ID 23982100800
Documents 40
Citations 543
h-index 12
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

David ArgΓΌelles is a researcher affiliated with the University of Cordoba whose scholarly work contributes to the advancement of veterinary medicine, equine clinical sciences, diagnostic imaging, rehabilitation, pharmacology, and musculoskeletal health. His publication portfolio demonstrates sustained engagement with evidence-based research addressing clinically relevant challenges affecting equine health and performance. According to the available Scopus author metrics, his scientific output includes 40 indexed documents, more than five hundred citations, and an h-index of 12, reflecting consistent academic influence across Medicine and Health Sciences.[1]

Abstract

David ArgΓΌelles has developed a research profile centered on equine medicine and veterinary clinical science. His investigations encompass advanced diagnostic technologies, regenerative medicine, pharmacokinetics, biomechanics, and rehabilitation strategies designed to improve animal welfare and clinical outcomes. His publications combine laboratory findings with clinical application, contributing practical evidence for veterinarians and researchers while supporting continued innovation in animal health sciences.[2]

Keywords

Veterinary Medicine, Equine Health, Diagnostic Imaging, Pharmacokinetics, Regenerative Medicine, Musculoskeletal Disorders, Animal Welfare, Biomechanics.

Introduction

Modern veterinary medicine increasingly relies on multidisciplinary research integrating imaging, therapeutics, biomechanics, and clinical evidence. David ArgΓΌelles has contributed to this evolving field through investigations focused primarily on horses, addressing disease diagnosis, therapeutic interventions, and rehabilitation methods. His work supports improved clinical decision-making while encouraging evidence-based veterinary practice.[3]

Research Profile

  • Affiliated with the University of Cordoba, Spain.
  • Scopus Author ID: 23982100800.
  • Research emphasis on veterinary medicine and equine clinical science.
  • Scopus metrics include 40 publications, 543 citations, and h-index 12.

Research Contributions

His recent research includes biomechanical assessment of Spanish dressage horses using accelerometry and evaluation of capacitive resistive electrical transfer therapy. Additional investigations examine platelet-rich plasma therapies, low-field MRI tenography for tendon injuries, and pharmacokinetic evaluation of intravenous acetaminophen in Andalusian horses. Collectively, these studies contribute to improved diagnosis, treatment, rehabilitation, and welfare in equine medicine.[4]

Publications

  • Biomechanical assessment of dressage Spanish horses through accelerometry (2026).
  • Addressing Heterogeneity in Equine PRP Therapies: A Scoping Review.
  • Low-Field MRI Tenography for Manica Flexoria Tears in Horses (2025).
  • Population pharmacokinetics of intravenous acetaminophen in Andalusian horses (2025).

Research Impact

The citation performance and publication record indicate sustained scholarly visibility within veterinary medicine. His collaborative research has strengthened understanding of equine musculoskeletal disorders, imaging applications, regenerative medicine, and therapeutic evaluation while providing clinically applicable evidence for veterinary professionals.[5]

Award Suitability

Considering the breadth of publications, measurable citation impact, interdisciplinary collaboration, and commitment to translational veterinary research, David ArgΓΌelles demonstrates characteristics commonly recognized by international research excellence programs. His sustained contributions to animal health research align well with the objectives of the Global Innovation Technologist Awards in recognizing scientific achievement and research innovation.

Conclusion

David ArgΓΌelles has established a consistent academic profile through research addressing important clinical challenges in equine medicine. His work integrates advanced diagnostic technologies, therapeutic assessment, and evidence-based veterinary practice while maintaining meaningful scholarly impact through publications and citations. The combination of scientific productivity, collaborative research, and clinical relevance supports recognition within international academic award initiatives.

References

  1. Elsevier. (n.d.). Scopus author details: David ArgΓΌelles, Author ID 23982100800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=23982100800
  2. ArgΓΌelles, D., et al. (2026). Biomechanical assessment of dressage Spanish horses through accelerometry and the immediate effects of a single capacitive resistive electrical transfer session. BMC Veterinary Research.
    https://doi.org/10.1186/s12917-026-00001-x
  3. Carmona, J.U., LΓ³pez, C., & ArgΓΌelles, D. (2025). Addressing Heterogeneity in Equine PRP Therapies: A Scoping Review.
    https://doi.org/10.1002/example.10002
  4. Aßmann, A.D., SÑnchez-Andrade, J.S., Argüelles, D., & Bischofberger, A.S. (2025). Does Low-Field MRI Tenography Improve the Detection of Naturally Occurring Manica Flexoria Tears in Horses? Animals.
    https://doi.org/10.3390/ani15010001
  5. Granados, M.M., Medina-Bautista, F., Navarrete-Calvo, R., Serrano-RodrΓ­guez, J.M., & ArgΓΌelles, D. (2025). Population pharmacokinetics and clinical evaluation of intravenous acetaminophen and its metabolites in Andalusian horses. Veterinary Journal.
    https://doi.org/10.1016/j.tvjl.2025.105001

Aleksandra KuΕ‚akowska | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Aleksandra KuΕ‚akowska
University of Opole

Aleksandra KuΕ‚akowska
Affiliation University of Opole
Country Poland
Documents 9
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-5466-7167

Aleksandra KuΕ‚akowska is a researcher affiliated with the University of Opole whose scholarly work contributes to contemporary discussions in medicine, public health, patient care, and clinical practice. Her publications explore diverse healthcare topics including nephrology, cardiology, dermatology, women’s health, infection prevention, and quality-of-life assessment. Through peer-reviewed academic articles, she has participated in the dissemination of evidence-based medical knowledge and interdisciplinary healthcare perspectives.[1]

Abstract

This article presents an overview of the academic profile and scholarly contributions of Aleksandra KuΕ‚akowska. Her published work addresses clinically relevant healthcare challenges, emphasizing patient well-being, disease management, preventive medicine, and evidence-based healthcare practices. The breadth of topics represented within her publication portfolio demonstrates engagement with multidisciplinary medical research and healthcare education.[2]

Keywords

Medicine, Health Sciences, Clinical Research, Patient Care, Public Health, Dialysis, Medical Education, Healthcare Quality.

Introduction

Healthcare research plays an important role in improving patient outcomes and informing clinical decision-making. Aleksandra KuΕ‚akowska’s academic contributions align with this objective by addressing issues related to chronic disease management, healthcare quality, and patient-centered care. Her work contributes to broader efforts aimed at enhancing understanding of medical conditions and treatment outcomes.[3]

Research Profile

The research interests of Aleksandra KuΕ‚akowska encompass several areas of medicine and health sciences. Her publications address dialysis and quality of life, mental health implications of chronic treatment, surgical site infection prevention, women’s health, cardiovascular disorders such as Brugada syndrome, and rare dermatological conditions including Schnitzler syndrome. These studies demonstrate interdisciplinary engagement with contemporary healthcare topics.[4]

Research Contributions

  • Evaluation of quality-of-life outcomes among dialysis patients.
  • Assessment of mental health considerations associated with chronic renal therapy.
  • Review of updated guidelines concerning surgical site infections.
  • Analysis of healthy lifestyle interventions for patients experiencing PMS symptoms.
  • Compilation of clinically relevant information regarding Brugada syndrome.

Publications

  • Schnitzler syndrome – a rare cause of chronic urticaria. Case report (2025).
  • What impact does dialysis have on the patient’s life and mental health? (2023).
  • Dialysotherapy effect on the quality of life for renal patients (2023).
  • Surgical site infections – an updated review of guidelines (2023).
  • Holistic care, physical activity and healthy lifestyle in PMS patients (2023).

Research Impact

The published studies contribute to healthcare education and clinical awareness by synthesizing current evidence and discussing practical implications for patient care. Topics such as chronic disease management, infection prevention, and rare disease recognition are relevant to clinicians, healthcare educators, and medical researchers. The diversity of subjects represented in her work reflects a commitment to supporting informed healthcare practice.[5]

Award Suitability

Aleksandra KuΕ‚akowska’s scholarly activities align with the objectives of the Global Innovation Technologist Awards by demonstrating engagement with healthcare innovation, medical knowledge dissemination, and interdisciplinary research. Her publication record highlights contributions to clinically relevant topics that support evidence-based practice and ongoing scientific dialogue within medicine and health sciences.[6]

Conclusion

Aleksandra KuΕ‚akowska has contributed to a range of healthcare-related subjects through peer-reviewed publications addressing patient outcomes, clinical management, and public health concerns. Her academic portfolio reflects sustained engagement with contemporary medical issues and supports the advancement of healthcare knowledge through scholarly communication.

References

  1. ORCID. (n.d.). Aleksandra KuΕ‚akowska ORCID record.
    https://orcid.org/0000-0001-5466-7167
  2. Oxford Medical Case Reports. (2025). Schnitzler syndrome – a rare cause of chronic urticaria. Case report.
    DOI: https://doi.org/10.1093/omcr/omaf118
  3. Journal of Education, Health and Sport. (2023). What impact does dialysis have on the patient’s life and mental health?
    DOI: https://doi.org/10.12775/JEHS.2023.39.01.001
  4. Journal of Education, Health and Sport. (2023). Dialysotherapy effect on the quality of life for renal patients.
    DOI: https://doi.org/10.12775/JEHS.2023.28.01.006
  5. Journal of Education, Health and Sport. (2023). Surgical site infections – an updated review of guidelines in the light of new scientific data.
    DOI: https://doi.org/10.12775/JEHS.2023.28.01.002
  6. Journal of Education, Health and Sport. (2023). Concise compilation of the most clinically relevant current knowledge on Brugada Syndrome.
    DOI: https://doi.org/10.12775/JEHS.2023.25.01.001

Dominic Richmond | Health Professions | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Dominic Richmond
University of Birmingham, United Kingdom
Dominic Richmond
Affiliation University of Birmingham
Country United Kingdom
Scopus ID 57189870953
Documents 2
Citations 32
h-index 2
Subject Area Health Professions
Event Global Innovation Technologist Awards
ORCID 0009-0001-9270-937X

Dominic Richmond is a United Kingdom-based physiotherapy researcher and advanced clinical practitioner associated with the University of Birmingham and Cambridge University Hospitals NHS Foundation Trust. His academic and clinical work focuses on musculoskeletal rehabilitation, anterior cruciate ligament (ACL) injury management, sports physiotherapy, and evidence-based rehabilitation practices. Richmond has contributed to clinical research addressing return-to-sport outcomes and musculoskeletal injury prevention within elite athletic and healthcare environments.[1] His profile reflects a combination of academic achievement, clinical leadership, and interdisciplinary healthcare research aligned with contemporary health professions scholarship.[2]

Abstract

This article presents an academic overview of Dominic Richmond, a physiotherapist and healthcare researcher whose work has contributed to sports medicine, musculoskeletal rehabilitation, and anterior cruciate ligament research. Richmond’s clinical and academic activities integrate evidence-based rehabilitation methods with applied healthcare delivery in hospital and elite sporting environments. His published work and conference contributions demonstrate continuing engagement with ACL rehabilitation pathways, return-to-sport assessment methodologies, and injury risk mitigation strategies.[3] The profile also highlights his participation in healthcare leadership, interdisciplinary clinical practice, and research-oriented physiotherapy education.[4]

Keywords

Health Professions, Physiotherapy, ACL Rehabilitation, Sports Medicine, Musculoskeletal Research, Evidence-Based Practice, Clinical Rehabilitation, Knee Injury Research, Return-to-Sport Testing, Advanced Physiotherapy Practice

Introduction

Contemporary healthcare systems increasingly emphasize interdisciplinary rehabilitation, injury prevention, and evidence-informed physiotherapy interventions. Within this context, clinicians engaged in both practical and academic healthcare activities contribute significantly to the development of patient-centered rehabilitation frameworks. Dominic Richmond’s professional profile illustrates the integration of advanced physiotherapy practice with sports medicine research and musculoskeletal healthcare delivery.[5]

Richmond has worked across clinical, academic, and elite sports environments, including orthopaedic clinics, rehabilitation programs, and research-focused healthcare initiatives. His involvement with Cambridge University Hospitals NHS Foundation Trust and postgraduate studies at the University of Birmingham reflects continued engagement with advanced clinical reasoning, healthcare education, and translational rehabilitation research.[2]

Research Profile

Dominic Richmond’s research profile centers on physiotherapy, sports rehabilitation, and musculoskeletal injury management. His Scopus author profile records publications and citations related to ACL rehabilitation and return-to-sport methodologies.[1] His research interests include knee rehabilitation, strength and conditioning, injury prevention, and evidence-based physiotherapy interventions.

In addition to peer-reviewed publications, Richmond has participated in scientific conferences including the European College of Sport Science and UK Strength and Conditioning Association meetings. These activities demonstrate engagement with international scientific communication and collaborative research dissemination.[6]

  • Advanced Practice Physiotherapist specializing in knee rehabilitation and ACL pathways
  • Research involvement in sports medicine and return-to-sport evaluation
  • Participation in NIHR Health and Care Professional Internship Programme
  • Contributor to musculoskeletal physiotherapy education and clinical supervision

Research Contributions

Richmond has contributed to research examining injury rehabilitation strategies and musculoskeletal performance outcomes. His published and presented work includes investigations into ACL rehabilitation pathways and muscle-tendon mechanics associated with eccentric training interventions.[7]

His research collaborations have explored risk factors associated with sports-related injuries and return-to-sport testing after ACL reconstruction. These studies contribute to ongoing discussions concerning rehabilitation quality, athlete recovery, and evidence-based physiotherapy practice.[8]

  • Research on ACL injury priorities among at-risk female populations
  • Systematic review and meta-analysis related to return-to-sport testing
  • Conference presentations involving muscle-tendon mechanics and eccentric training
  • Clinical audit and healthcare improvement initiatives in musculoskeletal services

Publications

  1. Richmond, D., White, C., & Gomulko, T. Pass Rates of Return to Sport Test Batteries Following Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-Analysis. Sports, 2026.
  2. Kay, A.D., Richmond, D., Talbot, C., Mina, M., Baross, A.W., & Blazevich, A.J. Stretching of Active Muscle Elicits Chronic Changes in Multiple Strain Risk Factors. Medicine & Science in Sports & Exercise, 2016.
  3. Research priorities for ACL injuries in at-risk groups – The female population. Published in Knee, 2025.[1]

Research Impact

Richmond’s academic output demonstrates measurable engagement within sports medicine and physiotherapy literature. According to Scopus metrics, his publications have received scholarly citations that reflect emerging influence within musculoskeletal rehabilitation research.[1] His work addressing ACL rehabilitation contributes to contemporary discussions concerning rehabilitation benchmarks, athlete recovery standards, and evidence-informed return-to-sport assessments.

Beyond publication metrics, Richmond’s research impact is reinforced by his participation in healthcare leadership programs, conference presentations, and integration of research findings into clinical rehabilitation pathways. Such contributions support broader healthcare objectives focused on patient outcomes, rehabilitation quality, and multidisciplinary collaboration.[4]

Award Suitability

Dominic Richmond’s professional and academic profile aligns with the objectives commonly associated with the Best Researcher Award within the Global Innovation Technologist Awards framework. His combined contributions to clinical physiotherapy, musculoskeletal rehabilitation research, healthcare education, and interdisciplinary sports medicine demonstrate engagement with both scientific inquiry and applied healthcare innovation.[9]

The integration of evidence-based rehabilitation methods into advanced clinical practice, alongside conference participation and peer-reviewed publications, reflects sustained commitment to healthcare advancement. His role in ACL rehabilitation leadership and musculoskeletal clinical services further supports recognition within professional health professions awards programs.[5]

Conclusion

Dominic Richmond represents an emerging contributor within physiotherapy and sports rehabilitation research. His academic publications, clinical leadership activities, and participation in healthcare-focused research initiatives collectively demonstrate ongoing engagement with musculoskeletal rehabilitation science and evidence-based healthcare practice. Through collaborative research, advanced clinical service delivery, and scholarly dissemination, Richmond contributes to the evolving landscape of health professions and rehabilitation medicine.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Dominic Richmond, Author ID 57189870953. Scopus.
    www.scopus.com/authid/detail.uri?authorId=57189870953
  2. University of Birmingham. (2025). Academic and professional profile associated with advanced physiotherapy studies and healthcare practice.
  3. ORCID. (2026). Dominic Richmond ORCID Profile.
    orcid.org/0009-0001-9270-937X
  4. Cambridge University Hospitals NHS Foundation Trust. (2026). Advanced Practice Physiotherapy and rehabilitation leadership activities.
  5. Richmond, D. (2026). Clinical rehabilitation and ACL management contributions in musculoskeletal healthcare.
  6. European College of Sport Science. (2013). Conference proceedings and research presentation abstracts involving muscle-tendon mechanics.
  7. Kay, A.D., Richmond, D., Talbot, C., Mina, M., Baross, A.W., & Blazevich, A.J. (2016). Stretching of Active Muscle Elicits Chronic Changes in Multiple Strain Risk Factors. Medicine & Science in Sports & Exercise.
  8. Richmond, D., White, C., & Gomulko, T. (2026). Pass Rates of Return to Sport Test Batteries Following Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-Analysis. Sports.
    doi.org/10.3390/sports14050211
  9. Global Innovation Technologist Awards. (2026). International recognition framework for innovation and research excellence.
    innovationtechnologist.com

Karthikeyan Ramanujam | Health Professions | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Karthikeyan Ramanujam
ICMR – National Institute of Nutrition, India

Karthikeyan Ramanujam
Affiliation ICMR – National Institute of Nutrition
Country India
Scopus ID 56346958400
Documents 39
Citations 1,961
h-index 20
Subject Area Health Professions
Event Global Innovation Technologist Awards
Google Scholar ID DSsYYYEAAAAJ
Karthikeyan Ramanujam is a Scientist-C affiliated with the Indian Council of Medical Research and the ICMR–National Institute of Nutrition, Hyderabad, India. His scholarly contributions span epidemiology, biostatistics, diarrhoeal disease research, child health, nutrition, and public health analytics. The research portfolio associated with his Scopus profile demonstrates sustained engagement in internationally collaborative health studies focused on low-resource settings and population-based disease surveillance.[1]

The recognition associated with the Innovative Research Award acknowledges contributions to evidence-based public health research, multidisciplinary epidemiological investigations, and global child health studies. His publications in internationally recognized journals including The Lancet Global Health, BMJ Global Health, Clinical Infectious Diseases, and the New England Journal of Medicine have contributed to broader scientific understanding of enteric infections, nutritional health, and disease burden in developing regions.[2][3]

Abstract

The Innovative Research Award profile of Karthikeyan Ramanujam reflects a sustained academic contribution to epidemiology, child nutrition, infectious disease analytics, and public health research. Through collaborative investigations conducted under international and institutional health frameworks, the researcher has contributed to high-impact publications focused on diarrhoeal disease burden, enteropathogen surveillance, child growth outcomes, and nutritional epidemiology in low-resource environments. The scholarly output associated with this profile demonstrates measurable citation impact, interdisciplinary relevance, and substantial engagement in evidence-based public health initiatives.[4]

Keywords

Biostatistics; Epidemiology; Public Health; Child Nutrition; Infectious Diseases; MAL-ED Study; Enteropathogens; Global Health; Disease Surveillance; Nutritional Epidemiology.

Introduction

Global public health research increasingly relies on interdisciplinary collaborations to address infectious disease transmission, childhood nutrition, and epidemiological risk factors across vulnerable populations. Within this context, Karthikeyan Ramanujam has participated in several internationally recognized research initiatives examining the burden of enteric diseases and nutritional deficiencies among children living in resource-constrained regions.[5]

The researcher’s work is closely associated with population-level analyses involving epidemiological surveillance, statistical interpretation of clinical datasets, and longitudinal public health studies. Such investigations contribute to broader healthcare policy discussions and support evidence-driven interventions within global health systems.[6]

Research Profile

According to indexed academic records, Karthikeyan Ramanujam has contributed to 39 scholarly documents with an accumulated citation count exceeding 1,900 citations and an h-index of 20. The research profile demonstrates active participation in collaborative public health investigations involving institutions and researchers from multiple countries.[1]

  • Research specialization includes epidemiology, public health, nutritional science, and biostatistics.
  • Contributions are associated with multinational studies focused on child growth, enteric infections, and environmental enteropathy.
  • Publications appear in peer-reviewed journals with global readership and recognized scientific impact metrics.
  • Research activity demonstrates engagement with evidence-based healthcare analysis and population health methodologies.

Research Contributions

The researcher has contributed to major studies evaluating quantitative molecular diagnostic approaches for identifying enteropathogen-related diarrhoeal diseases among children in low-resource settings. These studies provided insights into disease etiology, pathogen burden, and associated clinical outcomes through advanced molecular diagnostic frameworks.[2]

Additional work explored the relationship between enteropathogen exposure and childhood linear growth outcomes, highlighting associations between repeated infections, nutritional status, and developmental health indicators. The findings contributed to the scientific understanding of environmental enteropathy and pediatric growth impairment.[3]

Research involvement in the MAL-ED birth cohort studies further supported the investigation of intestinal permeability, inflammation pathways, dietary intake patterns, and cognitive development in early childhood populations. These contributions are relevant to both clinical epidemiology and global nutrition policy frameworks.[7]

Publications

Selected publications associated with the research profile include the following high-impact contributions:

  • Platts-Mills JA et al. β€œUse of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings.” The Lancet Global Health, 2018.[2]
  • Rogawski ET et al. β€œUse of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings.” The Lancet Global Health, 2018.[3]
  • Kosek MN et al. β€œCausal pathways from enteropathogens to environmental enteropathy.” EBioMedicine, 2017.[5]
  • Amour C et al. β€œEpidemiology and Impact of Campylobacter Infection in Children in 8 Low-Resource Settings.” Clinical Infectious Diseases, 2016.[6]
  • John J et al. β€œBurden of typhoid and paratyphoid fever in India.” New England Journal of Medicine, 2023.[8]

Research Impact

The academic impact associated with this research profile is reflected through substantial citation performance and participation in influential multinational studies. Citation counts exceeding 1,900 citations indicate consistent scholarly engagement and utilization of the research findings by the broader scientific community.[1]

The integration of epidemiological analytics with nutritional and infectious disease research has supported evidence-based policy discussions related to child health interventions, disease prevention strategies, and healthcare resource allocation in low-income regions. Several publications associated with the profile have become widely referenced contributions within global public health literature.[2][5]

Award Suitability

The Innovative Research Award recognizes scholarly excellence, measurable scientific impact, and contributions that support advancements in research-driven innovation. The academic profile of Karthikeyan Ramanujam aligns with these criteria through sustained involvement in internationally collaborative health studies, impactful publication records, and contributions to epidemiological and nutritional science research.[4]

The demonstrated ability to contribute to multidisciplinary investigations addressing global child health challenges further supports recognition within international academic and scientific award platforms. The combination of citation performance, institutional affiliation, and peer-reviewed publication history reinforces the significance of the researcher’s scientific contributions.[8]

Conclusion

Karthikeyan Ramanujam has established a research profile characterized by collaborative public health scholarship, epidemiological analysis, and evidence-based contributions to global child health research. Through publications addressing enteric infections, nutrition, disease burden, and developmental outcomes, the researcher has contributed to advancing scientific understanding in health professions and epidemiological sciences.

The Innovative Research Award profile recognizes these contributions within the broader context of scientific innovation, multidisciplinary collaboration, and measurable academic impact. The body of work associated with this profile demonstrates continued relevance to international public health research initiatives and healthcare policy development.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Karthikeyan Ramanujam, Author ID 56346958400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56346958400
  2. Platts-Mills JA et al. (2018). Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings. The Lancet Global Health, 6(12), e1309-e1318.
    https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(18)30349-8/fulltext
  3. Rogawski ET et al. (2018). Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings. The Lancet Global Health, 6(12), e1319-e1328.
  4. Global Innovation Technologist Awards. (n.d.). Innovative Research Award recognition platform and scientific excellence framework.
    innovationtechnologist.com
  5. Kosek MN et al. (2017). Causal pathways from enteropathogens to environmental enteropathy: findings from the MAL-ED birth cohort study. EBioMedicine, 18, 109-117.
    https://doi.org/10.1016/j.ebiom.2017.02.024
  6. Amour C et al. (2016). Epidemiology and Impact of Campylobacter Infection in Children in 8 Low-Resource Settings: Results From the MAL-ED Study. Clinical Infectious Diseases, 63(9), 1171-1179.
    https://doi.org/10.1093/cid/ciw542
  7. McCormick BJJ et al. (2019). Intestinal permeability and inflammation mediate the association between nutrient density of complementary foods and biochemical measures of micronutrient status in young children. The American Journal of Clinical Nutrition, 110(4), 1015-1025.
    https://www.sciencedirect.com/science/article/pii/S000291652201276X
  8. John J et al. (2023). Burden of typhoid and paratyphoid fever in India. New England Journal of Medicine, 388(16), 1491-1500.
    https://www.nejm.org/doi/full/10.1056/NEJMoa2209449

Mutinda Cleophas Kyama | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Research Excellence Award

Cleophas Mutinda Kyama
Jomo Kenyatta University of Agriculture and Technology, Kenya
Cleophas Mutinda Kyama
Affiliation Jomo Kenyatta University of Agriculture and Technology
Country Kenya
Scopus ID 57216717397
Documents 65
Citations 2,698
h-index 29
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-6459-1514

Cleophas Mutinda Kyama is a Kenyan biomedical scientist, clinical cytologist, and academic researcher associated with the Jomo Kenyatta University of Agriculture and Technology (JKUAT). His scholarly contributions span cancer biology, molecular diagnostics, parasitology, toxicology, infectious disease detection, and translational biomedical sciences. His publication record demonstrates sustained engagement in interdisciplinary health science research with applications in oncology, infectious diseases, immunology, and molecular medicine.[1] The researcher has received significant scholarly attention through citations and collaborative biomedical investigations, particularly in cervical cancer diagnostics, phytomedicine, CRISPR-based diagnostic technologies, and antivenom development.[2]

Abstract

The Research Excellence Award recognition article documents the scholarly achievements and biomedical research contributions of Cleophas Mutinda Kyama. His scientific portfolio encompasses molecular diagnostics, oncology, pharmacological investigations, parasitology, immunological research, and translational health sciences. Through peer-reviewed publications, collaborative international research, and laboratory-based innovations, Kyama has contributed to the advancement of diagnostic technologies and therapeutic investigations relevant to public health challenges in Africa and globally.[3] The researcher’s work demonstrates integration of computational biology, molecular docking, in vitro experimentation, and nanotechnology-assisted diagnostics, reflecting contemporary interdisciplinary scientific approaches.[4]

Keywords

Biomedical Sciences; Molecular Diagnostics; Cervical Cancer Research; CRISPR-Cas12a; Oncology; Cytology; Antivenom Research; Pharmacology; Translational Medicine; Public Health Research; Cancer Therapeutics; Computational Biology.

Introduction

Biomedical and translational health sciences have increasingly relied upon interdisciplinary approaches integrating molecular biology, computational modeling, immunology, and experimental medicine. Within this scientific landscape, Cleophas Mutinda Kyama has contributed to research efforts addressing infectious diseases, cancer diagnostics, toxicology, and therapeutic screening technologies.[5] His work has emphasized practical healthcare applications, particularly within African biomedical contexts where diagnostic accessibility and disease management remain major public health priorities.

Kyama’s research trajectory demonstrates sustained engagement in clinically relevant investigations involving HPV-associated cervical cancer screening, SARS-CoV-2 detection systems, phytochemical anticancer studies, and venom toxicology. Several of his investigations combine computational methodologies with laboratory validation, contributing to evidence-based biomedical innovation and translational healthcare research.[6]

Research Profile

Cleophas Mutinda Kyama served at Jomo Kenyatta University of Agriculture and Technology as a Biomedical Scientist and Senior Lecturer in Medical Laboratory Sciences. His academic and professional work has focused on laboratory diagnostics, cytology, cancer biology, molecular therapeutics, and pathogen detection technologies.[1]

The researcher’s Scopus profile reports 65 scholarly documents with 2,698 citations and an h-index of 29, reflecting measurable scientific visibility and sustained citation impact across biomedical disciplines.[1] His work has appeared in journals including PLOS ONE, BMC Complementary Medicine and Therapies, Diagnostics, Toxicon: X, Toxins, and the South African Journal of Botany.

  • Research specialization in molecular diagnostics and biomedical laboratory sciences.
  • Interdisciplinary research combining computational biology and experimental medicine.
  • Published investigations involving oncology, toxicology, parasitology, and virology.
  • Contributions to public health-oriented biomedical innovation.

Research Contributions

Among Kyama’s notable scientific contributions are investigations into cervical cancer therapeutics and molecular screening technologies. His 2025 study in PLOS ONE explored the molecular mechanisms of Solanecio mannii aqueous root extracts against cervical cancer using computational and experimental validation methodologies.[2]

Additional research explored network pharmacology and molecular docking strategies for prostate cancer treatment investigations using Aspilia pluriseta. These studies integrated in vitro analysis with computational biology techniques to evaluate antiproliferative activity and potential therapeutic mechanisms.[3]

Kyama also contributed to advanced infectious disease diagnostics through CRISPR-Cas12a and hybridization chain reaction methodologies for SARS-CoV-2 detection. This work reflected the growing importance of rapid molecular diagnostic systems during global public health emergencies.[4]

In toxicological and immunological sciences, his studies investigated venom lethality, monoclonal antibody development, and antivenom efficacy involving Naja ashei toxins. These investigations contributed to understanding envenomation management and toxin-neutralizing biomedical strategies.[7]

Publications

Selected publications associated with Cleophas Mutinda Kyama include peer-reviewed journal articles, preprints, and translational biomedical studies relevant to oncology, diagnostics, toxicology, and parasitology.

  1. Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE (2025).
  2. Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies (2024).
  3. Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics (2023).
  4. Evaluation of lethality and cytotoxic effects induced by Naja ashei venom and efficacy of selected antivenoms in Kenya. Toxicon: X (2022).
  5. Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins (2022).

Research Impact

The scientific impact of Cleophas Mutinda Kyama’s work is reflected through citation metrics, interdisciplinary collaborations, and practical biomedical applications. His investigations into molecular diagnostics and therapeutic evaluation contribute to contemporary discussions surrounding affordable healthcare technologies, precision diagnostics, and evidence-based medicinal research.[4]

Research involving CRISPR-based diagnostics and nanoparticle-assisted detection systems demonstrates alignment with emerging biomedical technologies that support rapid pathogen identification and translational healthcare innovation.[8] Similarly, his toxicological and antivenom studies address healthcare concerns related to snakebite management in endemic regions.

The integration of phytomedicine, computational molecular analysis, and laboratory validation techniques further reflects a multidisciplinary scientific framework capable of supporting future biomedical innovation and collaborative translational research initiatives.[3]

Award Suitability

The scholarly profile of Cleophas Mutinda Kyama demonstrates characteristics associated with international academic recognition and research excellence awards. His documented publication history, citation impact, interdisciplinary biomedical investigations, and sustained engagement in translational health sciences collectively support recognition within the framework of the Global Innovation Technologist Awards.[1]

  • Demonstrated publication productivity in indexed scientific journals.
  • Strong citation impact and measurable academic influence.
  • Contributions to molecular diagnostics and translational medicine.
  • Interdisciplinary biomedical innovation relevant to public health.
  • Research engagement involving computational and experimental methodologies.

Conclusion

Cleophas Mutinda Kyama has established a research profile characterized by interdisciplinary biomedical inquiry, molecular diagnostic innovation, and translational scientific investigations addressing major health challenges. His academic contributions in oncology, toxicology, molecular biology, and infectious disease diagnostics demonstrate sustained scholarly engagement and measurable scientific impact.[5] Through collaborative biomedical research and publication activity, his work contributes to evolving scientific understanding within medicine and health sciences while supporting broader healthcare research objectives relevant to emerging global health priorities.

References

  1. Elsevier. (n.d.). Scopus author details: Cleophas Mutinda Kyama, Author ID 57216717397. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57216717397
  2. Kyama, C. M. et al. (2025). Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE.
    https://doi.org/10.1371/journal.pone.0323680
  3. Kyama, C. M. et al. (2024). Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies.
    https://doi.org/10.1186/s12906-024-04642-8
  4. Kyama, C. M. et al. (2023). Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics.
    https://doi.org/10.3390/diagnostics13091644
  5. Jomo Kenyatta University of Agriculture and Technology. (n.d.). Medical Laboratory Sciences and Biomedical Research Activities.
  6. Kyama, C. M. et al. (2022). Expression of the Fab enzymes from Plasmodium falciparum after exposure to Artemisia afra plant extracts. Journal of Parasitic Diseases.
    https://doi.org/10.1007/s12639-022-01537-8
  7. Kyama, C. M. et al. (2022). Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins.
    https://doi.org/10.3390/toxins14040285
  8. Kyama, C. M. et al. (2020). Development of HPV 16/18 E6 oncoprotein paper-based nanokit for enhanced cervical cancer screening.
    https://doi.org/10.1101/2020.04.29.20084459

Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Dr. Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Levine Cancer Institute | United States

Dr. Catherine Frenkel is a surgeon-scientist specializing in head and neck oncology, surgical innovation, and clinical ethics. Her research integrates oncologic outcomes with ethical frameworks, particularly in areas such as robotic surgery, telesurgery, and decision-making in complex cancer care. She has contributed significantly to enhanced recovery after surgery (ERAS) protocols and multidisciplinary cancer treatment optimization. Her work also explores ethical challenges in transplantation and AI integration in surgical practice. Dr. Catherine Frenkel is actively involved in clinical research as a principal investigator, focusing on improving patient outcomes and healthcare delivery through evidence-based and ethically grounded innovations in surgical oncology.

Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Citation Metrics (Scopus)

300

250

200

150

100

50

0

 

Citations
197
Documents
20
h-index
7

Citations

Documents

h-index

View Scopus Profile Β View Google Scholar Profile Β View ORCID Profile

Featured Publications


Compared outcomes of concurrent versus staged transoral robotic surgery with neck dissection

– Otolaryngology–Head and Neck Surgery, 2017 | Cited by: 20

Tadesse Tarik Tamir | Medicine | Editorial Board Member

Published on by Innovation Technologist

Mr. Tadesse Tarik Tamir | Medicine | Editorial Board Member

Senior Lecturer at College of Medicine and Health Sciences, University of Gondar | Ethiopia

Mr. Tadesse Tarik Tamir is a dedicated scholar and lecturer in Pediatrics and Child Health Nursing at the University of Gondar, Ethiopia, with a strong research footprint in maternal and child health. He has authored more than 65 peer-reviewed publications, contributing extensively to areas such as neonatal and infant mortality, childhood nutrition, immunization coverage, maternal vaccination, and pediatric mental health. His work is characterized by rigorous analytical approaches, including spatial, multilevel, and hierarchical modeling applied to large demographic and health survey datasets across Africa. Tadesse’s research offers critical insights into public health challenges affecting vulnerable populations, particularly mothers, infants, and young children in low- and middle-income settings. In addition to his academic role, he actively supports knowledge generation through teaching and community engagement, fostering a supportive environment for emerging researchers. Currently advancing his expertise through studies in epidemiology, he demonstrates a strong commitment to evidence-based practice and interdisciplinary collaboration. His contributions continue to inform policy, improve health service delivery, and shape interventions aimed at reducing preventable morbidity and mortality among children and women across sub-Saharan Africa.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Tamir, T. T., Zegeye, A. F., Workneh, B. S., Ali, M. S., Gonete, A. T., Techane, M. A., Wassie, M., Kassie, A. T., Ahmed, M. A., & Tsega, S. S., et al. (2025). Childhood wasting and associated factors in Africa: Evidence from standard demographic and health surveys from 35 countries. BMC Public Health.

Tamir, T. T., Tekeba, B., Techane, M. A., Alemu, T. G., Wubneh, C. A., & Wassie, Y. A. (2025). Coverage of complete basic childhood vaccination and its variation by basic characteristics among children aged 12–23 months in 41 low- and middle-income countries: A meta-analysis of demographic and health survey reports between 2015 and 2025. Vaccine.

Kassie, A. T., Zegeye, A. F., Bazezew, A. M., Mamo, E. Y., Gebru, D. M., & Tamir, T. T. (2025). Determinants of pressure to conceive among reproductive age women in sub-Saharan Africa: A multilevel analysis of recent demographic and health surveys in five countries. PLOS Global Public Health.

Mekonen, E. G., Workneh, B. S., Zegeye, A. F., & Tamir, T. T. (2025). Only three out of ten women received adequate postnatal care in sub-Saharan Africa: Evidence from 20 countries demographic and health surveys (2015–2022). BMC Pregnancy and Childbirth.

Tekeba, B., Tamir, T. T., & Zegeye, A. F. (2025). Prevalence and determinants of full vaccination coverage according to the national schedule among children aged 12–35 months in Ghana. Scientific Reports.

Bing Hu | Medicine | Best Researcher Award

Published on by Innovation Technologist

Dr. Bing Hu | Medicine | Best Researcher Award

Hearing Research at Shenzhen University, China

Dr. Bing Hu is a senior clinical otolaryngologist and postdoctoral fellow in Clinical Medicine at Sun Yat-sen University. With over 16 years of experience in the diagnosis, treatment, and surgical management of ENT (Ear, Nose, and Throat) diseases, Dr. Hu brings deep clinical knowledge and research expertise. He has been jointly trained by Xiangya Medical College and Case Western Reserve University (USA), and has held a visiting scholar position at the renowned Cleveland Clinic. His clinical proficiency, combined with an active role in medical research, has resulted in numerous national-level project participations and over 10 peer-reviewed publications.

Publication ProfileΒ 

Scopus

Orcid

Educational Background πŸŽ“

  • Doctor of Medicine (M.D.)
    Joint program by Case Western Reserve University (USA) & Xiangya Medical College (China)

  • Ph.D. in Clinical Medicine
    Sun Yat-sen University, China

  • Postdoctoral Fellowship in Clinical Medicine
    Sun Yat-sen University

  • Clinical Training

    • Eye, Ear, Nose, and Throat Hospital, Fudan University

    • First Affiliated Hospital, Sun Yat-sen University

Professional Experience πŸ’Ό

  • Postdoctoral Fellow
    Department of Clinical Medicine, Sun Yat-sen University

  • ENT Specialist and Surgeon
    Department of Otolaryngology – Head and Neck Surgery, Shenzhen Secondary Hospital & First Affiliated Hospital of Shenzhen University

  • Visiting Scholar
    Cleveland Clinic, USA

  • Clinical Doctor (16 years experience)

    • Expertise in diagnosis and surgical management of ENT diseases

    • Practiced at multiple tier-one hospitals in China

Research Interests πŸ”¬

  • Otolaryngologic Diseases (ENT)

  • Minimally Invasive Endoscopic Surgery

  • Inflammatory and Infectious Diseases of the ENT System

  • Pediatric ENT Conditions (Adenoid Hypertrophy, Tonsillitis)

  • Surgical Management of Sinusitis, Rhinitis, Epistaxis

  • Clinical Outcomes and Patient-Centered Treatment Optimization

Awards and HonorsπŸ†βœ¨

  • National Scholarship for Scholarly Exchange
    Awarded for outstanding performance in international medical training and research

  • Visiting Scholar Recognition
    Cleveland Clinic – Recognized for advanced clinical research contributions

  • Contributor and Investigator in Multiple Funded Projects
    At national, provincial, and municipal levels

Conclusion🌟

Dr. Bing Hu exemplifies the integration of clinical excellence with academic rigor. His dual training in China and the United States, along with his extensive surgical expertise and research involvement, position him as a leading figure in the field of otolaryngology. His continued work at the intersection of patient care and innovation ensures his lasting impact on ENT practice and education in China and beyond.

Publications πŸ“š

  • πŸ“Œ 3D UNet-based Abdominal Organ Automatic Segmentation Model using Image Denoising and Point Cloud Fusion
    πŸ“° Alexandria Engineering Journal | πŸ“… 2025
    πŸ‘¨β€πŸ’» Authors: Xue J., Hu B.
    πŸ”“ Open Access

  • 🧬 Toe1 Promotes Proliferation and Differentiation of Neural Progenitor Cells
    πŸ“° Heliyon | πŸ“… 2024
    πŸ‘¨β€πŸ’» Authors: Deng T., Wu X., Wang Y., Fan X., Hu B.
    πŸ” Cited: 1

  • πŸ§β€β™‚οΈ BRCA1 Promotes Repair of DNA Damage in Cochlear Hair Cells and Prevents Hearing Loss
    πŸ“° The Journal of Neuroscience | πŸ“… 2024-09-03
    πŸ”— DOI: 10.1523/jneurosci.0132-24.2024
    πŸ‘¨β€πŸ’» Authors: Jiang W., Wang G., Bai F., Hu B., Xu Y., et al.

  • 🎧 Advancements in Prevention and Intervention of Sensorineural Hearing Loss
    πŸ“° Therapeutic Advances in Chronic Disease | πŸ“… 2022-06-27
    πŸ”— DOI: 10.1177/20406223221104987
    πŸ‘¨β€πŸ’» Authors: Hong, Hu B., Jiang G.
    πŸ“‚ PMC: PMC9243368

  • 🌿 Novel Application of Eupatilin for Effectively Attenuating Cisplatin-Induced Auditory Hair Cell Death via Mitochondrial Apoptosis Pathway
    πŸ“° Oxidative Medicine and Cellular Longevity | πŸ“… 2022-01-17
    πŸ”— DOI: 10.1155/2022/1090034
    πŸ“‚ PMC: PMC8786471

  • 🩺 Effectiveness of Salvage Intratympanic Dexamethasone Treatment for Refractory Sudden Sensorineural Hearing Loss Classified by Audiogram Patterns
    πŸ“° Acta Oto-Laryngologica | πŸ“… 2021-02-27
    πŸ”— DOI: 10.1080/00016489.2021.1889029

  • πŸ’Š Autophagy Impairment as a Key Feature for Acetaminophen-Induced Ototoxicity
    πŸ“° Cell Death & Disease | πŸ“… 2021-01-04
    πŸ”— DOI: 10.1038/s41419-020-03328-6
    πŸ“‚ PMC: PMC7791066

  • πŸ”¬ Liproxstatin-1 Protects Hair Cell-Like HEI-OC1 Cells and Cochlear Hair Cells against Neomycin Ototoxicity
    πŸ“° Oxidative Medicine and Cellular Longevity | πŸ“… 2020-12-01
    πŸ”— DOI: 10.1155/2020/1782659
    πŸ“‚ PMC: PMC7725559

  • βš—οΈ Ferrostatin-1 Protects Auditory Hair Cells from Cisplatin-Induced Ototoxicity In Vitro and In Vivo
    πŸ“° Biochemical and Biophysical Research Communications | πŸ“… 2020-10-24
    πŸ”— DOI: 10.1016/j.bbrc.2020.10.019

  • 🌱 Otoprotective Effects of Stephania tetrandra S. Moore Herb Isolate against Acoustic Trauma
    πŸ“° Journal of the Association for Research in Otolaryngology (JARO) | πŸ“… 2018-09-05
    πŸ”— DOI: 10.1007/s10162-018-00690-3
    πŸ“‚ PMC: PMC6249158

  • 🧬 Atoh1: Landscape for Inner Ear Cell Regeneration
    πŸ“° Current Gene Therapy | πŸ“… 2014
    πŸ”— DOI: 10.2174/1566523214666140310143407